Self-renewing Sox9+ osteochondral stem cells in the postnatal skeleton

Stephanie Farhat, Bahaeddine Tilouche, Spencer Short, Medjie Piron, T. Mark Campbell, José Alex Lourenço Fernandes, Mariya Somyk, Hina Bandukwala, Eric Arezza, Quentin Sastourné-Arrey, Katherine Reilly, Maria Abou Chakra, Gary D. Bader, Leo Kunz, Timm Schroeder, Sasha Carsen, Pierre Mattar, F. Jeffrey Dilworth, Daniel L. CoutubioRxiv 2023 · DOI

TL;DR

Researchers have identified a specific population of Sox9+ osteochondral stem cells in the postnatal skeleton that are responsible for long-term bone growth and maintenance. Residing in the "resting zone" of the growth plate, these cells are the first postnatal skeletal stem cells (SSCs) definitively shown to self-renew and remain multipotent into adulthood in both mice and humans.

What Problem Does This Paper Address?

While it is well-known that young skeletal tissue regenerates almost seamlessly, this capacity declines sharply with age, trauma, and disease. To develop better regenerative therapies, scientists need to understand the "source code" of bone maintenance: the postnatal skeletal stem cell (SSC).

Until now, most research focused on embryonic or perinatal (around birth) stages. The location, molecular signature, and self-renewal capabilities of SSCs in the postnatal and adult skeleton remained elusive. This is largely due to technical hurdles: bone is notoriously difficult to image because it is hard, opaque, and highly autofluorescent. This paper aims to bridge that gap by identifying where these cells live, how they decide to divide or stay quiet, and how they change as we age.

Methods

The authors employed a sophisticated "multi-omic" and imaging approach:

  • Dual Lineage Tracing: They used a genetic mouse model (Sox9-CreERT;Ai14) where a pulse of Tamoxifen triggers a permanent red fluorescent signal (tdTomato) in cells expressing the transcription factor Sox9. Simultaneously, they used EdU (a thymidine analogue) to label actively dividing cells.
  • 3D Imaging Cytometry: To overcome the difficulty of imaging bone, the team used optical clearing and spectral confocal imaging. They processed these massive datasets using XiT, an open-source software they developed for 3D segmentation and quantification of cells within intact bone volumes.
  • Single-Cell Transcriptomics (scRNA-seq): They integrated their experimental data with existing single-cell datasets to map the molecular pathways (like Wnt and PDGF) regulating these cells.
  • In Vitro Assays: They isolated these cells to prove they could form colonies and differentiate into bone, cartilage, and fat in a lab setting.

Datasets

The study utilized several key data sources:

  • Newly Generated Data: 3D imaging datasets of postnatal mouse femurs and pediatric human bone samples (polydactyly digits).
  • Public Datasets: An open-access dataset of mouse skeletal cells (Ref 38) and previously published human single-cell transcriptomics data across various developmental stages (Ref 15).
  • Integrated Benchmarks: The authors created a new comparison between fetal (E16.5) and adult skeletal stem cell transcriptomes to highlight how plasticity changes over time.

Key Insights and Ideas

  • The "Resting Zone" is a Reservoir: The "resting zone" of the growth plate (physis) isn't just dormant; it is a specialized niche for slow-cycling, self-renewing stem cells.
  • Active Quiescence via Wnt Inhibition: These stem cells stay in a "stem-like" state by actively suppressing Wnt signaling. They express high levels of Wnt antagonists like Wif1 and Sfrp5. When these signals are bypassed, the cells begin the journey toward becoming mature bone or cartilage.
  • Sexual Dimorphism in Development: The study noted that female bones appear to undergo accelerated postnatal development compared to males, though these differences attenuate as the animals reach skeletal maturity.
  • Human Conservation: The researchers found a nearly identical population of Sox9+ cells in human pediatric bones, suggesting that the mechanisms discovered in mice are highly relevant to human orthopedics.
  • A New Marker (ITGB5): They identified Integrin β5 (ITGB5) as a potential surface marker that could be used to isolate and purify these stem cells from human tissues without needing genetic reporters.

Key Results

  • Persistence: Labeled Sox9+ cells were tracked for up to 180 days (6 months), proving they survive and continue to contribute to bone tissue long after the initial labeling.
  • Slow-Cycling Nature: Only about 2.89% of the labeled cells incorporated EdU during a short pulse, confirming they are "slow-cycling"—a classic hallmark of long-term resident stem cells.
  • Multipotency: In vitro, isolated Sox9+ cells successfully formed colonies and differentiated into osteoblasts (bone), chondrocytes (cartilage), and even adipocytes (fat).
  • Transcriptomic Divergence: While fetal and adult SSCs share a core signature, they cluster separately, explaining why fetal cells have higher "plasticity" (the ability to form a wider variety of tissues) than their adult counterparts.

Limitations and Future Work

The authors acknowledge that their findings are currently at the population level. While they proved the group of Sox9+ cells self-renews, they haven't yet tracked a single cell's entire "family tree" (clonal analysis) in vivo to see if one cell can truly do it all.

Additionally, isolating these cells from older, skeletally mature animals proved much more difficult than from younger ones. This suggests that as we age, these stem cells might undergo "exhaustion" or change their growth requirements. Future research will need to focus on how to "re-awaken" these cells in elderly patients to treat age-related bone loss and non-healing fractures.

Summary updated

Abstract

Abstract Postnatal skeletal growth, homeostatic maintenance, and regeneration is driven by skeletal stem cells. In addition, it is well established that skeletal tissues lose their regenerative potential with age, comorbidities, and repeated trauma, possibly through stem cell exhaustion or loss of function. However, it is largely unknown where these cells reside in skeletal tissues, what molecular mechanisms regulate their self-renewal and fate decisions, and how to isolate, purify, and expand them ex vivo. Therefore, there is an urgent need for a deeper understanding of postnatal skeletal stem cells. Here, we used genetic lineage tracing, thymidine analogues retention, whole bone microscopy, imaging cytometry, in vitro assays, and single cell transcriptomics and provide the first experimental evidence for the existence of self-renewing osteochondral stem cells in the postnatal skeleton in both males and females. We also show direct comparisons between adult, fetal, mouse, and human skeletal stem cells at the transcriptome level.
BibTeX
@misc{farhat2023self,
  author = {Stephanie Farhat and Bahaeddine Tilouche and Spencer Short and Medjie Piron and T. Mark Campbell and José Alex Lourenço Fernandes and Mariya Somyk and Hina Bandukwala and Eric Arezza and Quentin Sastourné-Arrey and Katherine Reilly and Maria Abou Chakra and Gary D. Bader and Leo Kunz and Timm Schroeder and Sasha Carsen and Pierre Mattar and F. Jeffrey Dilworth and Daniel L. Coutu},
  title = {{Self-renewing Sox9+ osteochondral stem cells in the postnatal skeleton}},
  year = {2023},
  doi = {10.1101/2023.12.07.570646},
  howpublished = {bioRxiv},
}
Figure